Neoplasms Connective Tissue

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-04-01
Clinical Trial Update: Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors [Phase 2, Phase 3]
A Neoadjuvant combination therapy trial using doxorubicin, cisplatin, and methotrexate in young adults with primary bone tumors has reported…